Dashboard
Manage Tickers

ME


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

23andme-and-nightingale-health-announced-a-strategic-collaboration-to-pilot-nightingale-healths-blood-metabolomics-panel-with-a-cohort-of-23andme-members
23andMe And Nightingale Health Announced A...
06/28/2024 11:33:12

As part of the pilot, 23andMe will offer up to 5,000 23andMe+ Premium and Total Health members the opportunity to receive blood...

looking-into-23andme-holdings-recent-short-interest
Looking Into 23andMe Holding's Recent Shor...
06/12/2024 19:15:21

Core News & Articles
Canada Authority Says Canada And UK Privac...
06/10/2024 14:12:14

- Reuters

23andme-therapeutics-present-preliminary-phase-2-safety-and-efficacy-results-for-23me-00610-targeting-cd200r1-at-the-2024-asco-annual-meeting
23andMe Therapeutics Present Preliminary P...
06/03/2024 12:21:59

– 23ME-00610 monotherapy demonstrates preliminary evidence of clinical benefit, including one confirmed partial response – 23ME...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
05/23/2024 20:31:02

23andme-board-on-mar-28-formed-special-committee-to-review-strategic-alternatives-for-maximizing-shareholder-value-on-apr-18-announced-ceo-anne-wojcicki-considering-proposal-to-acquire-remaining-outstanding-shares-says-in-light-of-review-not-providing-guidance
23andMe Board On Mar. 28 Formed Special Co...
05/23/2024 20:11:25

23andme-holding-q4-2024-gaap-eps-043-sales-64028m-beat-55822m-estimate
23andMe Holding Q4 2024 GAAP EPS $(0.43), ...
05/23/2024 20:07:32

23andMe Holding (NASDAQ:ME) reported quarterly losses of $(0.43) per share. The company reported quarterly sales of $64.028 mi...

Core News & Articles
Petros Pharmaceuticals Launches U.S. Distr...
05/14/2024 13:23:12

Lemonaid Health will offer customers more affordable access to branded ED medication STENDRA that may be taken as early as ~15 ...

23andme-holding-granted-additional-180-days-or-until-nov-4-to-regain-compliance-with-minimum-bid-price-requirement-for-continued-listing
23andMe Holding Granted Additional 180 Day...
05/10/2024 20:30:31

-SEC Filing

23andme-to-present-preliminary-efficacy-and-biomarker-data-for-23me-00610-at-the-2024-asco-annual-meeting
23andMe To Present Preliminary Efficacy An...
04/24/2024 20:51:50

23andMe Holding Co. (NASDAQ:ME) ("23andMe"), a leading human genetics and biopharmaceutical company, today announced th...

nasdaq-down-05-lithium-americas-shares-slide
Nasdaq Down 0.5%; Lithium Americas Shares ...
04/18/2024 18:54:52

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
04/18/2024 16:31:41

crude-oil-edges-lower-bio-path-holdings-shares-spike-higher
Crude Oil Edges Lower; Bio-Path Holdings S...
04/18/2024 16:08:16

once-valued-at-billions-23andmes-ceo-considers-privatization-to-secure-companys-future
Once Valued At Billions, 23andMe's CEO Con...
04/18/2024 16:06:23

Anne Wojcicki, CEO of 23andMe mulls taking the genetics company private amid market challenges. With declining revenue and a fo...

why-las-vegas-sands-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Las Vegas Sands Shares Are Trading Low...
04/18/2024 15:32:50

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
04/18/2024 12:09:32

23andme-reveals-ceos-intention-to-pursue-potential-take-private
23andMe Reveals CEO's Intention To Pursue ...
04/18/2024 12:05:19

Wojcicki currently owns shares constituting more than 20% of the total outstanding shares and entitling her to approximately 49...

as-reported-in-amended-13d-filing-wednesday-23andme-ceo-anne-wojcicki-told-board-she-is-considering-proposal-to-take-co-private
As Reported In Amended 13D Filing Wednesda...
04/18/2024 11:18:03

citigroup-maintains-neutral-on-23andme-holding-lowers-price-target-to-047
Citigroup Maintains Neutral on 23andMe Hol...
04/16/2024 14:40:09

Citigroup analyst Daniel Grosslight maintains 23andMe Holding (NASDAQ:ME) with a Neutral and lowers the price target from $0...

23andme-to-present-data-on-two-clinical-stage-immuno-oncology-programs-at-the-aacr-annual-meeting-2024
23andMe To Present Data On Two Clinical St...
04/05/2024 20:06:46

23ME-01473, antibody targeting ULBP6: Data will be presented on the discovery and biology of ULBP6, and the potential to restor...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)